COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Post by plovieon Feb 13, 2007 8:54am

180 Views

Post# 12223150

I listened to the webcast yesterday.

Unbelievable, when you look at the big picture! A drug company with this deep of a pipeline, with excellent partners. I wonder why this stock hasn't moved, is this company really that buried in the unknown. This year will be full of Phase 1/2/3 trial results, along with parterning and licensing deals. Anyone see any potential negatives, besides a failure in the trials.

Bullboard Posts

Nextech CEO provides company update on Amazon deal and more